Search Results - "Tolstov, S. N."

Clinical Observation of Asymptomatic Left Atrial Myxoma by Sergeeva, V. A., Tolstov, S. N., Sychkova, E. D.

“…Myxomas are the most common type of primary benign cardiac tumor in adults, with an incidence of about 0.2 % in the population at autopsy. Myxomas develop from…”
Get full text

Altered vascular stiffness and central pulse wave parameters in climacteric women by Salov, I. A., Tolstov, S. N., Rebrov, A. P.

“…Aim: to assess changes in parameters of vascular stiffness, central aortic pressure (CAP) as well as reflected pulse wave in women in different phases of the…”
Get full text

The Traumatogenic Factors of Life-Style of Rural Population by Deryabkina, L V, Tolstov, S N, Karaseva, T V

“…The article substantiates actuality of problem, presents study methodology and classification of leading traumatogenic factors of life-style of rural…”
Get more information

Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts by Galyavich, A. S., Fomin, I. V., Gaisin, I. R., Valeeva, F. V., Vinogradova, N. G., Salasyuk, A. S., Tarlovskaya, E. I., Khasanov, N. R., Shutov, A. M., Volodina, E. N., Grekhova, L. V., Guseva, P. S., Duplyakov, D. V., Zanozina, O. V., Zolotova, Yu. V., Kanysheva, S. V., Kim, Z. F., Kononov, S. K., Kuzmin, V. P., Markiyanova, S. S., Menzorov, M. V., Pomosov, S. A., Rebrov, A. P., Tolstov, S. N.

“…At an online meeting of experts held on May 14, 2021 additional research results on a sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin in…”
Get full text

Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR-Reduced trial” by Villevalde, S. V., Galyavich, A. S., Vinogradova, N. G., Volodina, E. N., Gaisin, I. R., Gilyarevsky, S. R., Grekhova, L. V., Guryanova, Yu. A., Guseva, P. S., Duplyakov, D. V., Ezhov, A. V., Zakirova, N. E., Zolotova, Yu. V., Isakov, A. V., Kanysheva, S. V., Kim, Z. F., Kuzmin, V. P., Markiyanova, S. S., Pomosov, S. A., Rebrov, A. P., Tarlovskaya, E. I., Tolstov, S. N., Fomin, I. V., Khasanov, N. R., Shutov, A. M.

“…An online meeting of experts held on November 6, 2020 describes the results of EMPA-REG OUTCOME and EMPEROR-Reduced trials on sodium-glucose co-transporter-2…”
Get full text

Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial by Arutyunov, G. P., Arutyunov, A. G., Tarlovskaya, E. I., Ametov, A. S., Vinogradova, N. G., Garganeeva, A. A., Glezer, M. G., Zhirov, I. V., Ilyin, M. V., Koziolova, N. A., Konradi, A. O., Lebedeva, A. Yu, Lopatin, Yu. M., Nedogoda, S. V., Salukhov, V. V., Sitnikova, M. Yu, Tereshchenko, S. N., Tolstov, S. N., Khalimov, Yu. Sh, Khasanov, N. R., Chesnikova, A. I., Giga, V., Paсker, M.

“…At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and…”
Get full text

SPECIFICS OF METABOLIC SYNDROME PATHOPHYSIOLOGY IN WOMEN AT DIFFERENT PHASES OF CLIMACTERIC PERIOD by Mychka, V. B., Tolstov, S. N., Salov, I. A.

“…Aim. To study the specifics of metabolic syndrome (MS) course in women at different stages of climacterics and relationship with body mass and adipose tissue…”
Get full text

ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE by Tolstov, S. N., Salov, I. A., Rebrov, A. P.

“…Aim. To evaluate the nature of the dysfunction of the endothelium in postmenopausal women with climacteric syndrome, peculiarities of its changes during…”
Get full text

BLOOD PRESSURE VARIABILITY AND THE CONDITION OF TARGET ORGANS IN MENOPAUSAL WOMEN by Tolstov, S. N., Mychka, V. B., Salov, I. A.

“…Aim. To study the correlation of arterial pressure variability on brachial artery and central arterial pressure variability with condition of target organs…”
Get full text

OPEN-LABEL RANDOMIZED CROSS-SECTIONAL STUDY OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL VALSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION by Mychka, V. B., Vertkin, A. L., Tolstov, S. N., Prokhorova, Yu. V., Uzuyeva, E. I., Khamurzova, М. А.

“…To compare antihypertensive effectiveness and changes of lipid and carbohydrate metabolism profiles, erectile function and life quality in patients with…”
Get full text

Metabolic (cytoprotective) therapy of menopausal disturbances by Tolstov, S. N., Mychka, V. B.

“…The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role…”
Get full text

MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM by Mychka, V. B., Tolstov, S. N., Salov, I. A., Prokhorova, Yu. V., Uzueva, E. I., Vertkin, A. L.

“…Numerous publications on the use of p-blockers in patients with arterial hypertension (AH) and metabolic syndrome (MS) have reported adverse effects of these…”
Get full text

PARTIAL FATTY ACID OXIDATION (P-FOX) INHIBITORS AND COMBINED THERAPY OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS by M. E. Statsenko, S. V. Turkina, S. N. Tolstov

Get full text

Cardiovascular risk factors in women and the role of sex hormones by Yureneva, S. V., Mychka, V. B., Ilyina, L. M., Tolstov, S. N.

“…Despite certain success in the recent years, the problem of cardiovascular disease (CVD) in women remains one of the greatest challenges of the 21st century…”
Get full text

Cardiorenal disturbances in perimenopausal women by Tolstov, S. N., Mychka, V. B., Salov, I. A., Prokhorova, Yu. V., Vyshivanyuk, V. A.

“…Aim. To identify early signs of renal dysfunction; to investigate the associations between renal function and vascular remodelling; to evaluate the role of…”
Get full text

MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN by S. N. Tolstov, I. A. Salov, V. B. Mychka, M. Yu. Kirillova, N. A. Voychenko, I. V. Kuznetsova

“…The review outlines the main mechanisms of protective estrogen effects on cardiovascular system and the role of estrogen deficiency in cardiovascular disease…”
Get full text

Comparative effectiveness of the approaches to correct vascular structural and functional disturbances in postmenopausal women by Tolstov, S. N., Mychka, V. B., Salov, I. A., Prokhorova, Yu. V., Vyshivanyuk, V. A.

“…Aim. To compare the effects of Mildronate and hormone replacement therapy (HRT) with estradiol (1 mg) and drospirenone, DSPR (2 mg) on circadian blood pressure…”
Get full text

Cardiovascular prevention in peri- and postmenopausal women by Voychenko, N. A., Kuznetsova, I. V., Mychka, V. B., Kirillova, M. Yu, Tolstov, S. N.

“…The adverse consequences of estrogen deficiency in postmenopause include cardiovascular disease (CVD), which affects not only women’s quality of life, but also…”
Get full text

P2536Protective effects of ultra-low-dose menopausal hormonal therapy on endothelium function in postmenopausal women by Tolstov, S N, Salov, I A, Rebrov, A P

“…Abstract Introduction This is the first pilot study to assess the functional state of the vascular wall in postmenopausal women on the background of ultra…”
Get full text

P3460Structural and functional changes of vascular wall in women of perimenopausal period with long-term menopausal hormone therapy by Tolstov, S N, Salov, I A, Rebrov, A P

“…Abstract Introduction Features of changes in the vascular wall in women of the menopausal period are not sufficiently illuminated. Most of the studies…”
Get full text